Edoxaban Tosylate and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Edoxaban Tosylate and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: edoxaban
Brand name: Savaysa
Synonyms: Edoxaban
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Edoxaban Tosylate-Insulin degludec
- Edoxaban Tosylate-Insulin Degludec (U-100) Prefilled Pens
- Edoxaban Tosylate-Insulin Degludec (U-100) Vials
- Edoxaban Tosylate-Insulin Degludec (U-200) Prefilled Pens
- Edoxaban Tosylate-Insulin degludec and liraglutide
- Edoxaban Tosylate-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Edrophonium and Atropine
- Insulin aspart, recombinant Subcutaneous-Edrophonium Injection
- Insulin aspart, recombinant Subcutaneous-Edurant
- Insulin aspart, recombinant Subcutaneous-EEMT
- Insulin aspart, recombinant Subcutaneous-EEMT DS
- Insulin aspart, recombinant Subcutaneous-EEMT HS